Arecor Therapeutics plc (LON:AREC – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Friday . The company traded as low as GBX 54.75 ($0.67) and last traded at GBX 57 ($0.70), with a volume of 62242 shares changing hands. The stock had previously closed at GBX 74 ($0.90).
Arecor Therapeutics Stock Down 23.0 %
The company has a debt-to-equity ratio of 5.51, a current ratio of 1.37 and a quick ratio of 6.24. The stock has a market cap of £21.52 million, a price-to-earnings ratio of -203.57 and a beta of -0.18. The firm’s 50-day moving average is GBX 73.29 and its 200 day moving average is GBX 81.27.
About Arecor Therapeutics
Arecor Therapeutics plc is a biopharmaceutical company transforming patient care by bringing innovative medicines to market. Through the enhancement of existing medicines using our Arestat™ technology, we are developing a broad portfolio of therapies as part of our proprietary pipeline and through partnerships with leading pharmaceutical and biotech companies.
See Also
- Five stocks we like better than Arecor Therapeutics
- Conference Calls and Individual Investors
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- Upcoming IPO Stock Lockup Period, Explained
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
